
Chemical and Pharmaceutical Bulletin p. 1266 - 1269 (1993)
Update date:2022-09-26
Topics:
Itokawa
Kondo
Hitotsuyanagi
Nakamura
Morita
Takeya
Several aromatic ring substituent modified RA derivatives were prepared from RA-VII (I), RA-V (8) and RA-II (II), and evaluated for cytotoxicity against P388 leukemia and KB cells. In terms of IC50 values, the C(ζ) methoxyl group of Tyr-3 greatly influenced the activities, while the substituents at the C(ζ) position of Tyr-6 were less important. One of the derivatives, Tyr-6-C(ζ)-deoxyRA-V (9, P388, IC50, 0.0025μg/ml) was nearly as active as RA-VII (1, 0.0013 μg/ml), and also expressed promising anti- P388 in vivo activity (test/control = 171%, at 25 mg/kg).
View MoreContact:86-10-62983737; +86-10-51287608
Address:4/F Building C, 2 Shangdi Xinxi Road
SHANXI XINTIANYUAN PHARMACEUTICAL CO., LTD.
website:http://www.tychemical.com
Contact:0086-358-3521713 3521715
Address:No. 1 Yintong Road, Shanxi Jiaocheng Economic Development Zone, Xiajiaying Town, Jiaocheng County, Lvliang City, Shanxi Province, China
Xi'an Galaxy Chemicals CO., Ltd
Contact:86-29-89380370
Address:No.8, Gaoxin three road, Xi'an city.
Xi'an Tizan Tech & Industry Co., Ltd.
Contact:86-18629066522
Address:C3009 TANG FENG INTERNATIONAL PLAZA, NO.18 FENGHUI NAN ROAD, XI'AN HIGH TECH ZONE, 710075 CHINA.
GUANGZHOU MEDCAN PHARMATECH LTD
website:http://www.gzmedcan.com
Contact:+86-20-82519649
Address:Building J,Room 101,1 JiangtashanRd,Guang Zhou Science City,Guang Zhou ,China
Doi:10.1002/jhet.5570300411
(1993)Doi:10.1016/S0040-4039(00)60409-4
(1993)Doi:10.1055/s-1994-25460
(1994)Doi:10.1039/c3dt52655k
(2014)Doi:10.1016/j.molstruc.2013.11.026
(2014)Doi:10.1016/j.carres.2013.11.016
(2014)